Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. KalVista Pharmaceuticals Inc shares valued at $397,929 were sold by Feener Edward P. on Feb 20 ’24. At $14.07 per share, Feener Edward P. sold 28,288 shares. The insider’s holdings dropped to 62,157 shares worth approximately $0.7 million following the completion of this transaction.
Also, Crockett Thomas Andrew sold 24,888 shares, netting a total of over 351,289 in proceeds. Following the sale of shares at $14.11 each, the insider now holds 211,203 shares.
Before that, Palleiko Benjamin L had sold 22,802 shares from its account. In a trade valued at $321,846, the CFO, CBO traded KalVista Pharmaceuticals Inc shares for $14.11 each. Upon closing the transaction, the insider’s holdings decreased to 22,802 shares, worth approximately $2.1 million.
As published in their initiating research note from H.C. Wainwright on June 15, 2020, KalVista Pharmaceuticals Inc [KALV] has been a Buy and the price target has been revised to $30. Analysts at SVB Leerink started covering the stock with ‘”an Outperform”‘ outlook in a report released in late July. As of March 20, 2019, Needham has initiated its “Buy” rating for KALV. Earlier on October 30, 2018, Jefferies initiated its rating. Their recommendation was “a Buy” for KALV stock.
Analyzing KALV Stock Performance
During the last five days, there has been a surge of approximately 1.26%. Over the course of the year, KalVista Pharmaceuticals Inc shares have dropped approximately -8.49%. Shares of the company reached a 52-week high of $16.88 on 02/01/24 and a 52-week low of $10.70 on 03/26/24. A 50-day SMA is recorded $13.40, while a 200-day SMA reached $10.79. Nevertheless, trading volume fell to 0.5 million shares from 0.22 million shares the previous day.
Support And Resistance Levels for KalVista Pharmaceuticals Inc (KALV)
According to the 24-hour chart, there is a support level at 10.96, which, if violated, would cause prices to drop to 10.72. In the upper region, resistance lies at 11.44. The next price resistance is at 11.67. RSI (Relative Strength Index) is 39.03 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.41, which suggests the price will decrease in the coming days. Percent R is at 74.50%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
Is KalVista Pharmaceuticals Inc subject to short interest?
Stocks of KalVista Pharmaceuticals Inc saw a sharp rise in short interest on Mar 15, 2024 jumping by 1.93 million shares to 4.92 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 2.99 million shares. A jump of 39.23% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.25 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.25.
